Module Database Search



MODULE DESCRIPTOR
Module Title
Clinical Pharmacology and Therapeutics 2
Reference PH4131 Version 5
Created August 2021 SCQF Level SCQF 10
Approved March 2013 SCQF Points 45
Amended August 2021 ECTS Points 22.5

Aims of Module
To integrate scientific principles and clinical skills to evidence-based therapeutics relating to specific body systems including the application of pharmacokinetic principles.

Learning Outcomes for Module
On completion of this module, students are expected to be able to:
1 Critically evaluate the pathophysiology, pharmacology and evidence-based therapeutics of commonly occurring disease states.
2 Analyse patient information to identify pharmacological and therapeutic issues.
3 Synthesise therapeutic strategies in relation to a range of diseases.
4 Manipulate, interpret and apply pharmacological and pharmacokinetic data in varying clinical situations.
5 Integrate and apply practical clinical skills to patients’ clinical needs.

Indicative Module Content
Integration of the scientific principles and clinical skills required of a pharmacist to develop evidence−based therapeutic plans for individual patients in the context of specific disease states including: infectious diseases; malignant disorders; musculo-skeletal diseases; cardiovascular system; gastrointestinal system, respiratory system; pain; immune system; haematology and therapeutic drug monitoring; clinical skills including communication, consultation, data gathering from case notes, physical assessment.

Module Delivery
Lectures, coursework sessions (that include individual problem solving exercises and group based problem-based learning, tutorial sessions) and directed study (that include computer packages, directed reading and self−assessment exercises).

Indicative Student Workload Full Time Part Time
Contact Hours 98 N/A
Non-Contact Hours 352 N/A
Placement/Work-Based Learning Experience [Notional] Hours N/A N/A
TOTAL 450 N/A
Actual Placement hours for professional, statutory or regulatory body    

ASSESSMENT PLAN
If a major/minor model is used and box is ticked, % weightings below are indicative only.
Component 1
Type: Practical Exam Weighting: 50% Outcomes Assessed: 4, 5
Description: A practical exam on evidence-based therapeutics and case study material.
Component 2
Type: Examination Weighting: 50% Outcomes Assessed: 1, 2, 3
Description: A problem based learning written assessment assessing the therapeutic detail of the problem based learning case studies.

MODULE PERFORMANCE DESCRIPTOR
Explanatory Text
The first grade represents Component 1 (EX1) equally weighted with the second, Component 2 (EX2). A minimum of Module Grade D is required to pass the module. Non-submission of either component will result in an NS grade.
Module Grade Minimum Requirements to achieve Module Grade:
A AA,AB,BA
B AC,AD,BB,BC,CA,CB,DA
C BD,CC,CD,DB,DC
D DD
E AE,AF,BE,BF,CE,CF,DE,EA,EB,EC,ED,EE,FA,FB,FC
F DF,FE,FD,EF,FF
NS Non-submission of work by published deadline or non-attendance for examination

Module Requirements
Prerequisites for Module Successful completion of MPharm stage 2.
Corequisites for module None.
Precluded Modules None.

INDICATIVE BIBLIOGRAPHY
1 BLENKINSOPP A., PAXTON P. Symptoms in the Pharmacy. Current edition. Oxford: Blackwell Science.
2 RANG H.P., DALE M.M., RITTER J.M., FLOWER R.J., HENDERSON G. Pharmacology. Current edition. Edinburgh: Churchill Livingstone.
3 TORTORA, G.J., DERRICKSON, B.H. Principles of Anatomy and Physiology. Current edition. New York: J Wiley and Sons.
4 WALKER R., WHITTLESEA C. Clinical Pharmacy and Therapeutics. Current edition. Edinburgh: Churchill Livingstone.

Robert Gordon University, Garthdee House, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781